EU To Seek Joint Advance Contracts On COVID-19 Vaccines

NGOs Say The Move Could Spur A Race For Preferential Access

Countries naturally want their citizens to have access to any COVID-19 vaccines once they are developed and approved. The European Commission has asked the EU member states for a mandate to negotiate advance contracts on their behalf with pharmaceutical firms, but some are worried the initiative lacks transparency and could lead to unhealthy competition for access at the global level. 

microbiologist with a tube of biological sample contaminated by Coronavirus with label Covid-19 / doctor in the laboratory with a biological tube for analysis and sampling of Covid-19 infectious disea
Work is under way on a multitude of potential COVID-19 vaccines • Source: Shutterstock

EU health ministers are due to discuss on 12 June a European Commission proposal to negotiate advance purchase agreements for COVID-19 vaccines with pharmaceutical companies, a move designed to ensure the bloc has enough supplies of vaccines once they become available.

The commission wants member states to give it a mandate to conduct such negotiations on their behalf on the grounds...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Europe

  • EU Biosimilar Filings, Opinions And Approvals

     
    • By 

    <p>Executive Summary</p> <p>A list of EU biosimilar filings, CHMP opinions and EU marketing authorizations, including details of the biosimilar company, the brand name/INN, indication(s), the reference product/company, and the date and type of event.</p>

  • EU Pharma Reform: What You Need to Know Now

     

    As the reform of the EU pharmaceutical legislation progresses through the legislative process, the Pinks Sheet offers an infographic highlighting some of the key changes being proposed that will reshape the way drug companies run their business.

  • New EU Approvals

    <p>Executive Summary<p> <p>The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add six new products, incl/ding Ixchiq, Valneva's chikungunya virus vaccine</p>

More from Geography